TM9SF1 and acute respiratory distress syndrome: When median TM9SF1 expression levels were used to stratify patients into low- and high-risk groups, high-risk patients presented with a 3.03-fold increase in ARDS severity as compared to low-risk patients (OR = 4.03, 95% CI = 3.75–6.36, P < 0.001).